Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report (2016)

Letters16 August 2016Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case ReportDaniel S. Chertow, MD, MPH, Avindra Nath, MD, Anthony F. Suffredini, MD, Robert L. Danner, MD, Daniel S. Reich, MD, PhD, Rachel J. Bishop, MD, Richard W. Childs, MD, Andrew E. Arai, MD, Tara N. Palmore, MD, H. Clifford Lane, MD, Anthony S. Fauci, MD, and Richard T. Davey, MDDaniel S. Chertow, MD, MPHFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Avindra Nath, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Anthony F. Suffredini, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Robert L. Danner, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Daniel S. Reich, MD, PhDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Rachel J. Bishop, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Richard W. Childs, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Andrew E. Arai, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Tara N. Palmore, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., H. Clifford Lane, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Anthony S. Fauci, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., and Richard T. Davey, MDFrom Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M15-3066 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Meningoencephalitis has been described as an acute or late complication of Ebola virus disease (EVD) (1–3), but detailed physical examination and brain magnetic resonance imaging (MRI) findings have not been reported. Here we report findings in a patient with severe EVD complicated by meningoencephalitis and multiorgan failure managed with supportive care only.Case Report: A 34-year-old male health care worker in Sierra Leone was evacuated on day 7 of documented EVD to the National Institutes of Health Clinical Center. On arrival, he had no discrete cognitive abnormalities. Figure 1 describes his clinical course.Figure 1.Sequential multiorgan failure in a ...References1. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054-7. [PMID: 25372854] doi:10.1056/NEJMp1413084 CrossrefMedlineGoogle Scholar2. Edwards JK, Kleine C, Munster V, Giuliani R, Massaquoi M, Sprecher A, et al. Interpretation of negative molecular test results in patients with suspected or confirmed Ebola virus disease: report of two cases. Open Forum Infect Dis. 2015;2:ofv137. [PMID: 26512358] doi:10.1093/ofid/ofv137 CrossrefMedlineGoogle Scholar3. Howlett P, Brown C, Helderman T, Brooks T, Lisk D, Deen G, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone [Letter]. Emerg Infect Dis. 2016;22:150-2. [PMID: 26690042] doi:10.3201/eid2201.151212 CrossrefMedlineGoogle Scholar4. Bechtelsheimer H, Korb G, Gedigk P. [The "Marburg-virus"-hepatitis Studies in man and guinea pigs]. Virchows Arch A Pathol Pathol Anat. 1970;351:273-90. [PMID: 5312756] CrossrefMedlineGoogle Scholar5. Slenczka WG. The Marburg virus outbreak of 1967 and subsequent episodes. Curr Top Microbiol Immunol. 1999;235:49-75. [PMID: 9893378] MedlineGoogle Scholar6. Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, et al. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis. 2007;196 Suppl 2:S323-8. [PMID: 17940967] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; National Eye Institute, National Institutes of Health, Bethesda, Maryland;National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.Disclaimer: The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.Acknowledgment: The successful care of this patient is attributed to the efforts of the multidisciplinary team at the National Institutes of Health Clinical Center. This team comprised volunteers and included Special Clinical Studies Unit and critical care nurses, respiratory therapists, a radiology technician, laboratory technicians, a pharmacist, a dietitian, hospital epidemiologists, critical care and infectious diseases physicians, and WatSans from diverse backgrounds. To these individuals, the authors express their gratitude.Grant Support: The Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health, supported this work.Disclosures: Dr. Reich reports grants from Vertex Pharmaceuticals outside the submitted work. Authors not named here have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-3066.This article was published at www.annals.org on 5 April 2016. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byLongitudinal in vivo imaging of acute neuropathology in a monkey model of Ebola virus infectionThe neurological sequelae of pandemics and epidemicsEbola: A review and focus on neurologic manifestationsEbola virus diseasePeripheral Neuronopathy Associated With Ebola Virus Infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola PatientsNeuroimaging in Zoonotic Outbreaks Affecting the Central Nervous System: Are We Fighting the Last War?"No Man is an Island" John DonnePathogenesis of Uveitis in Ebola Virus Disease Survivors: Evolving Understanding from Outbreaks to Animal ModelsLongitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine DesignThe Emerging Threat of EbolaModeling Challenges of Ebola Virus–Host Dynamics during Infection and TreatmentNew treatments for Ebola virus diseaseUnderstanding long-term effects of Ebola virus diseaseCase Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra LeoneNeurological syndromes driven by postinfectious processes or unrecognized persistent infectionsSequelae of Ebola Virus DiseaseEvidence of Ebola Virus Replication and High Concentration in Semen of a Patient During RecoveryInsights from clinical research completed during the west Africa Ebola virus disease epidemicUpdate and new insights in encephalitisHigh-Containment Pathogen Preparation in the Intensive Care UnitCardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus DiseaseNeurological Complications and Sequelae of Ebola Virus DiseaseLongitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus diseaseOphthalmic Manifestations and Causes of Vision Impairment in Ebola Virus Disease Survivors in Monrovia, LiberiaThe Pathogenesis of Ebola Virus DiseaseInfections of the CerebellumEbola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journeyNeurological Complications of Ebola Virus InfectionWest Africa 2013: Re-examining EbolaWest Africa 2013: Re-examining Ebola 16 August 2016Volume 165, Issue 4Page: 301-304KeywordsBrainCentral nervous systemEbola virusLesionsMeningoencephalitisSerum glutamic oxaloacetic transaminaseSpinal cordTechniciansUveitisWhite blood cells ePublished: 5 April 2016 Issue Published: 16 August 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...